Sökning: onr:"swepub:oai:lup.lub.lu.se:5d212ac4-9236-4897-96f3-876753670906" >
DDR1/2 enhance KIT ...
DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors
-
- Liu, Anbu (författare)
- Ningxia Medical University
-
- Zhang, Shaoting (författare)
- Ningxia Medical University
-
- Wang, Ming (författare)
- Ningxia Medical University
-
visa fler...
-
- Zhang, Liangying (författare)
- Ningxia Medical University
-
- Xu, Shidong (författare)
- Tongren Hospital Shanghai Jiao Tong University School Of Medicine
-
- Nasimian, Ahmad (författare)
- Lund University,Lunds universitet,Avdelningen för translationell cancerforskning,Institutionen för laboratoriemedicin,Medicinska fakulteten,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Division of Translational Cancer Research,Department of Laboratory Medicine,Faculty of Medicine,LUCC: Lund University Cancer Centre,Other Strong Research Environments
-
- Li, Shujing (författare)
- Ningxia Medical University
-
- Zhao, Sien (författare)
- Ningxia Medical University
-
- Cao, Xu (författare)
- Ningxia Medical University
-
- Tian, Jinhai (författare)
- Ningxia Medical University
-
- Yu, Yuanyuan (författare)
- Ningxia Medical University
-
- Fan, Zhaoyang (författare)
- Ningxia Medical University
-
- Xiao, Kun (författare)
- Ningxia Medical University
-
- Zhao, Hui (författare)
- Chinese University of Hong Kong
-
- Kazi, Julhash U. (författare)
- Lund University,Lunds universitet,Avdelningen för translationell cancerforskning,Institutionen för laboratoriemedicin,Medicinska fakulteten,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Division of Translational Cancer Research,Department of Laboratory Medicine,Faculty of Medicine,LUCC: Lund University Cancer Centre,Other Strong Research Environments
-
- Ma, Lijun (författare)
- Tongren Hospital Shanghai Jiao Tong University School Of Medicine
-
- Sun, Jianmin (författare)
- Ningxia Medical University
-
visa färre...
-
(creator_code:org_t)
- 2024
- 2024
- Engelska 19 s.
-
Ingår i: Molecular Carcinogenesis. - 0899-1987. ; 63:1, s. 75-93
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Gastrointestinal stromal tumors (GISTs) are predominantly initiated by KIT mutations. In this study, we observed that discoidin domain receptors 1 and 2 (DDR1 and DDR2) exhibited high expression in GISTs, were associated with KIT, and enhanced the activation of both wild-type KIT and primary KIT mutants. Inhibition of DDR1/2 led to a reduction in the activation of KIT and its downstream signaling molecules, ultimately impairing GIST cell survival and proliferation in vitro. Consequently, treatment of mice carrying germline KIT/V558A mutation with DDR1/2 inhibitor significantly impeded tumor growth, and the combined use of DDR1/2 inhibitor and imatinib, the first-line targeted therapeutic agent for GISTs, markedly enhanced tumor growth suppression. In addition, DDR1/2 inhibition resulted in decreased KIT expression, while KIT inhibition led to upregulation of DDR1/2 expression in GISTs. The presence of DDR1/2 also decreased the sensitivity of wild-type KIT or primary KIT mutants to imatinib, indicating a possible role for DDR1/2 in promoting GIST survival during KIT-targeted therapy. The development of drug-resistant secondary KIT mutations is a primary factor contributing to GIST recurrence following targeted therapy. Similar to primary KIT mutants, DDR1/2 can associate with and enhance the activation of secondary KIT mutants, further diminishing their sensitivity to imatinib. In summary, our data demonstrate that DDR1/2 contribute to KIT activation in GISTs and strengthen resistance to imatinib for both primary and secondary KIT mutants, providing a rationale for further exploration of DDR1/2 targeting in GIST treatment.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- DDR
- GIST
- imatinib
- KIT
- mutation
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Liu, Anbu
-
Zhang, Shaoting
-
Wang, Ming
-
Zhang, Liangying
-
Xu, Shidong
-
Nasimian, Ahmad
-
visa fler...
-
Li, Shujing
-
Zhao, Sien
-
Cao, Xu
-
Tian, Jinhai
-
Yu, Yuanyuan
-
Fan, Zhaoyang
-
Xiao, Kun
-
Zhao, Hui
-
Kazi, Julhash U.
-
Ma, Lijun
-
Sun, Jianmin
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Molecular Carcin ...
- Av lärosätet
-
Lunds universitet